Compare FENC & KG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FENC | KG |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 258.5M | 225.0M |
| IPO Year | 2001 | N/A |
| Metric | FENC | KG |
|---|---|---|
| Price | $7.57 | $10.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 196.5K | 26.1K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 8.50 |
| Revenue | ★ $38,790,000.00 | $26,676,137.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $75.22 | N/A |
| P/E Ratio | ★ N/A | $1.23 |
| Revenue Growth | N/A | ★ 1610.20 |
| 52 Week Low | $4.68 | $10.11 |
| 52 Week High | $9.92 | $36.80 |
| Indicator | FENC | KG |
|---|---|---|
| Relative Strength Index (RSI) | 42.20 | 24.25 |
| Support Level | $7.35 | $11.70 |
| Resistance Level | $7.74 | $14.50 |
| Average True Range (ATR) | 0.36 | 1.01 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 20.00 | 9.59 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Kestrel Group Ltd is specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.